Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | MIF | P14174 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9706316 | 0.95 | CYP1A2 (0.48) | CYP1A2NAAAKEAP1NFE2L2PTGS2 | |
| SCHEMBL1457047 | 0.89 | CYP1A2 (0.44) | CYP1A2NAAAKEAP1NFE2L2PTGS2 | |
| SCHEMBL49063 | 0.83 | CYP1A2 (0.52) | CYP1A2PTGS2NR1I2PGRADORA3 | |
| SCHEMBL13664664 | 0.81 | TSHR (0.54) | NAAAKEAP1NFE2L2PTGS2MIF | |
| Bromide SCHEMBL18889105 | 0.80 | CYP1A2 (0.36) | CYP1A2NAAAKEAP1NFE2L2PTGS2 | |
| SCHEMBL13144471 | 0.79 | CYP1A2 (0.55) | CYP1A2PTGS2NR1I2PGRADORA3 | |
| SCHEMBL8851842 | 0.79 | CYP1A2 (0.55) | CYP1A2PTGS2NR1I2PGRADORA3 | |
| Bromide SCHEMBL18889143 | 0.77 | CYP1A2 (0.35) | CYP1A2NAAAMGAMGAASI | |
| SCHEMBL11260906 | 0.76 | CYP1A2 (0.48) | CYP1A2PTGS2NR1I2PGRADORA3 | |
| SCHEMBL1201485 | 0.76 | CYP1A2 (0.48) | CYP1A2PTGS2NR1I2PGRADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4240339-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | Fred Hutchinson Cancer Center (US) | 2023-09-13 | — | — | EP | disclosed |
| US-20230263800-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | FRED HUTCHINSON CANCER CENTER (US) | 2023-08-24 | — | — | US | disclosed |
| WO-2022098776-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2022-05-12 | — | — | WO | disclosed |
| US-20210113573-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC REGENERATION | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2021-04-22 | — | — | US | disclosed |
| US-10556878-B2 | Thiourea compounds and their use as inhibitors of Sirt2 or Sirt5 | CORNELL UNIVERSITY (US) | 2020-02-11 | — | — | US | disclosed |
| US-20160130246-A1 | THIOUREA COMPOUNDS AND THEIR USE AS INHIBITORS OF SIRT2 OR SIRT5 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-05-12 | — | — | US | disclosed |
| US-20160130246-A1 | THIOUREA COMPOUNDS AND THEIR USE AS INHIBITORS OF SIRT2 OR SIRT5 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-05-12 | — | — | US | disclosed |
| US-20160120945-A1 | Thymic Regeneration | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2016-05-05 | — | — | US | disclosed |
| EP-2956545-A1 | THYMIC REGENERATION | JOSLIN DIABETES CENTER (US) | 2015-12-23 | — | — | EP | disclosed |
| WO-2014127198-A1 | THYMIC REGENERATION | JOSLIN DIABETES CENTER (US) | 2014-08-21 | — | — | WO | disclosed |
| US-7795255-B2 | Rigidified compounds for modulating heparanase activity | INSIGHT BIOPHARMACEUTICALS LTD. (IL) | 2010-09-14 | — | — | US | disclosed |
| US-20080039456-A1 | Rigidified Compounds for Modulating Heparanase Activity | INSIGHT BIOPHARMACEUTICALS LTD. (IL) | 2008-02-14 | — | — | US | disclosed |
| EP-1846383-A2 | RIGIDIFIED COMPOUNDS FOR MODULATING HEPARANASE ACTIVITY | Insight Biopharmaceuticals Ltd. (IL) | 2007-10-24 | — | — | EP | disclosed |
| WO-2006072953-A2 | RIGIDIFIED COMPOUNDS FOR MODULATING HEPARANASE ACTIVITY | INSIGHT BIOPHARMACEUTICALS LTD. (IL) | 2006-07-13 | — | — | WO | disclosed |
| EP-1149106-B1 | 4,5-AZOLO-OXINDOLES | HOFFMANN LA ROCHE (CH) | 2003-03-19 | — | — | EP | disclosed |
| EP-1149106-A2 | 4,5-AZOLO-OXINDOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2001-10-31 | — | — | EP | disclosed |
| US-6197804-B1 | KINASE INHIBITORS; ANTICANCER AGENTS | HOFFMANN-LA ROCHE INC. | 2001-03-06 | — | — | US | disclosed |
| US-6153634-A | FOR THERAPY AND PROPHYLAXIS OF CANCER TUMORS; INHIBITOR OFCYCLIN-DEPENDENT KINASES (CDKS) | HOFFMANN-LA ROCHE INC. (US) | 2000-11-28 | — | — | US | disclosed |
| WO-2000035920-A2 | 4,5-AZOLO-OXINDOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-22 | — | — | WO | disclosed |
| WO-1992013530-A1 | TRANSGLUTAMINASE ENZYME INHIBITORS | MEDICIS CORPORATION (US) | 1992-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210113573-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC REGENERATION | BMP4, NOD2, BMP2 | CYP1A2 4746/4885NAAA 4720/4885KEAP1 3593/4885 |
| US-20160130246-A1 | THIOUREA COMPOUNDS AND THEIR USE AS INHIBITORS OF SIRT2 OR SIRT5 | SIRT2, SIRT3, SIRT1 | CYP1A2 848/4885NAAA 2128/4885KEAP1 729/4885 |
| US-20230263800-A1 | COMPOSITIONS AND METHODS TO PROMOTE THYMIC FUNCTION | BMP4, P2RY2, GPR39 | CYP1A2 4213/4885NAAA 4611/4885KEAP1 4389/4885 |
| US-10556878-B2 | Thiourea compounds and their use as inhibitors of Sirt2 or Sirt5 | SIRT2, SIRT3, SIRT1 | CYP1A2 848/4885NAAA 2128/4885KEAP1 729/4885 |
| US-20080039456-A1 | Rigidified Compounds for Modulating Heparanase Activity | HPSE, HEXA, GAA | CYP1A2 3723/4885NAAA 1643/4885KEAP1 2213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.